Suppr超能文献

全球范围内的卫生技术评估中的循证决策过程:探索卫生技术评估的下一个前沿和最佳实践 评“全球卫生技术评估机构使用循证决策过程”。

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".

机构信息

Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.

Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.

出版信息

Int J Health Policy Manag. 2021 Mar 14;10(4):232-236. doi: 10.34172/ijhpm.2020.145.

Abstract

This comment reflects on an article by Oortwijn, Jansen, and Baltussen about the use and features of 'evidence-informed deliberative processes' (EDPs) among health technology assessment (HTA) agencies around the world and the need for more guidance. First, we highlight procedural aspects that are relevant across key steps of EDP, focusing on conflict of interest, the different roles of stakeholders throughout a HTA and public justification of decisions. Second, we discuss new knowledge and models needed to maximize the value of deliberative processes at the expanding frontiers of HTA, paying special attention to when HTA is applied in primary care, employed for public health interventions, and is produced through international collaboration.

摘要

这篇评论反思了 Oortwijn、Jansen 和 Baltussen 撰写的一篇文章,内容涉及全球卫生技术评估 (HTA) 机构使用和体现“循证审议过程” (EDP) 的情况,以及对更多指导意见的需求。首先,我们突出了 EDP 各关键步骤中相关的程序方面,重点讨论利益冲突、HTA 全过程中利益相关者的不同角色以及决策的公众论证。其次,我们讨论了在 HTA 的不断扩展前沿领域最大限度提高审议过程价值所需的新知识和模型,特别关注当 HTA 应用于初级保健、用于公共卫生干预措施以及通过国际合作产生时的情况。

相似文献

3
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
Int J Health Policy Manag. 2020 Jan 1;9(1):27-33. doi: 10.15171/ijhpm.2019.72.
5
Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
Int J Health Policy Manag. 2022 Oct 19;11(10):2319-2326. doi: 10.34172/ijhpm.2021.158. Epub 2021 Nov 10.
6
Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
Int J Health Policy Manag. 2022 Oct 19;11(10):2327-2336. doi: 10.34172/ijhpm.2021.159. Epub 2021 Nov 10.

本文引用的文献

3
Harnessing the power of health taxes.
BMJ. 2020 Jun 18;369:m1436. doi: 10.1136/bmj.m1436.
4
5
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
Int J Health Policy Manag. 2020 Jan 1;9(1):27-33. doi: 10.15171/ijhpm.2019.72.
7
Health Technology Assessment of Public Health Interventions Published 2012 to 2016: An Analysis of Characteristics and Comparison of Methods.
Int J Technol Assess Health Care. 2019;35(4):280-290. doi: 10.1017/S0266462319000515. Epub 2019 Jul 24.
8
From the National Health Service to local government: perceptions of public health transition in England.
Public Health. 2019 Sep;174:11-17. doi: 10.1016/j.puhe.2019.05.016. Epub 2019 Jun 29.
10
European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.
Wien Med Wochenschr. 2019 Sep;169(11-12):284-292. doi: 10.1007/s10354-019-0684-0. Epub 2019 Feb 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验